| Keyword search (4,163 papers available) | ![]() |
"drugs" Keyword-tagged Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people | London-Nadeau K; Barborini C; Haines-Saah R; Bazarov M; Bristowe S; Khorkhordina M; Lemay-Gaulin M; Gorka C; Juster RP; D' Alessio H; Chadi N; | 40633507 PSYCHOLOGY |
| 2 | Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies | Lu H; Hong T; Jiang Y; Whiteway M; Zhang S; | 37307922 BIOLOGY |
| 3 | Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence | Mahri M; Shen N; Berrizbeitia F; Rodan R; Daer A; Faigan M; Taqi D; Wu KY; Ahmadi M; Ducret M; Emami E; Tamimi F; | 33181361 CONCORDIA |
| 4 | Chronic Neuroleptic-Induced Parkinsonism Examined with Positron Emission Tomography. | Galoppin M, Berroir P, Soucy JP, Suzuki Y, Lavigne GJ, Gagnon JF, Montplaisir JY, Stip E, Blanchet PJ | 32353194 PERFORM |
| 5 | Hydrated electrons induce the formation of interstrand cross-links in DNA modified by cisplatin adducts | Behmand B; Noronha AM; Wilds CJ; Marignier JL; Mostafavi M; Wagner JR; Hunting DJ; Sanche L; | 32211848 CHEMBIOCHEM |
| 6 | Adolescent media use and its association to wellbeing in a Canadian national sample. | Fitzpatrick C, Burkhalter R, Asbridge M | 31024788 PERFORM |
| Title: | Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies | ||||
| Authors: | Lu H, Hong T, Jiang Y, Whiteway M, Zhang S | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/37307922/ | ||||
| DOI: | 10.1016/j.addr.2023.114960 | ||||
| Publication: | Advanced drug delivery reviews | ||||
| Keywords: | Antifungal drugs; Antifungal immunotherapy; Antifungal targets; Candidiasis; Cutaneous infection; Systemic infection; | ||||
| PMID: | 37307922 | Category: | Date Added: | 2023-06-13 | |
| Dept Affiliation: | BIOLOGY | ||||
Description: |
Candidiasis is an infection caused by fungi from a Candida species, most commonly Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on human skin and mucous membranes of the mouth, intestines or vagina. It can cause a wide variety of mucocutaneous barrier and systemic infections; and becomes a severe health problem in HIV/AIDS patients and in individuals who are immunocompromised following chemotherapy, treatment with immunosuppressive agents or after antibiotic-induced dysbiosis. However, the immune mechanism of host resistance to C. albicans infection is not fully understood, there are a limited number of therapeutic antifungal drugs for candidiasis, and these have disadvantages that limit their clinical application. Therefore, it is urgent to uncover the immune mechanisms of the host protecting against candidiasis and to develop new antifungal strategies. This review synthesizes current knowledge of host immune defense mechanisms from cutaneous candidiasis to invasive C. albicans infection and documents promising insights for treating candidiasis through inhibitors of potential antifungal target proteins. |



